Suppr超能文献

产黄青霉合成山梨素的机制与调控

Mechanism and regulation of sorbicillin biosynthesis by Penicillium chrysogenum.

作者信息

Guzmán-Chávez Fernando, Salo Oleksandr, Nygård Yvonne, Lankhorst Peter P, Bovenberg Roel A L, Driessen Arnold J M

机构信息

Molecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands.

Synthetic Biology and Cell Engineering, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands.

出版信息

Microb Biotechnol. 2017 Jul;10(4):958-968. doi: 10.1111/1751-7915.12736. Epub 2017 Jun 15.

Abstract

Penicillium chrysogenum is a filamentous fungus that is used to produce β-lactams at an industrial scale. At an early stage of classical strain improvement, the ability to produce the yellow-coloured sorbicillinoids was lost through mutation. Sorbicillinoids are highly bioactive of great pharmaceutical interest. By repair of a critical mutation in one of the two polyketide synthases in an industrial P. chrysogenum strain, sorbicillinoid production was restored at high levels. Using this strain, the sorbicillin biosynthesis pathway was elucidated through gene deletion, overexpression and metabolite profiling. The polyketide synthase enzymes SorA and SorB are required to generate the key intermediates sorbicillin and dihydrosorbicillin, which are subsequently converted to (dihydro)sorbillinol by the FAD-dependent monooxygenase SorC and into the final product oxosorbicillinol by the oxidoreductase SorD. Deletion of either of the two pks genes not only impacted the overall production but also strongly reduce the expression of the pathway genes. Expression is regulated through the interplay of two transcriptional regulators: SorR1 and SorR2. SorR1 acts as a transcriptional activator, while SorR2 controls the expression of sorR1. Furthermore, the sorbicillinoid pathway is regulated through a novel autoinduction mechanism where sorbicillinoids activate transcription.

摘要

产黄青霉是一种丝状真菌,用于工业规模生产β-内酰胺。在经典菌株改良的早期阶段,由于突变,产生黄色山梨素类化合物的能力丧失。山梨素类化合物具有高度生物活性,在制药领域具有重大意义。通过修复工业产黄青霉菌株中两个聚酮合酶之一的关键突变,高水平恢复了山梨素类化合物的生产。利用该菌株,通过基因缺失、过表达和代谢物谱分析阐明了山梨素生物合成途径。聚酮合酶SorA和SorB是生成关键中间体山梨素和二氢山梨素所必需的,随后它们被FAD依赖性单加氧酶SorC转化为(二氢)山梨醇,并被氧化还原酶SorD转化为最终产物氧代山梨醇。两个pks基因中的任何一个缺失不仅影响总产量,还会强烈降低途径基因的表达。表达通过两个转录调节因子SorR1和SorR2的相互作用进行调控。SorR1作为转录激活因子,而SorR2控制sorR1的表达。此外,山梨素类化合物途径通过一种新的自诱导机制进行调控,即山梨素类化合物激活转录。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ead/5481523/96df186f6302/MBT2-10-958-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验